Skip to content

Use of block of beta tricalcium phosphate to enhance the bone disponibility for the implants placement

Use of block of beta tricalcium phosphate to enhance the bone disponibility in edentulous alveolar ridges: A randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6hbztw
Enrollment
Unknown
Registered
2016-09-28
Start date
2015-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar bone loss

Interventions

Patients will be randomly divided into two groups: Control group: 20 patients will be submit to the surgical procedure for the autograft placement
Group test: 20 patients will be submit to the surgical procedure for the autograft placement of the b-tricalcium phosphate blocks
Procedure/surgery
E04.555.130

Sponsors

Faculdade de Odontologia de Araraquara-Unesp
Lead Sponsor
Faculdade de Odontologia de Araraquara-Unesp
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having aged between 18 and 60; presence of edentulous alveolar ridges of less than 4 mm thick, which characterizes the need to increase bone availability for subsequent implants placement; good systemic health; provide at least 1 year of healing of the dental post-extraction socket.

Exclusion criteria

Exclusion criteria: Smokers and former smokers; diabetes;chronic or aggressive periodontitis ; users of medications wich alters the bone metabolism; cronical users of anti-inflammatories and antibiotics; bruxism; alcoholics; chemical dependents; pregnant or who wish to become pregnant in the next year; history of radiotherapy in the head and neck regions; patients with diseases affecting bone metabolism.

Design outcomes

Primary

MeasureTime frame
The difference volume stability of grafts that will by evaluate by tomographic analysis take into consideration a difference between the groups of 10.90%

Secondary

MeasureTime frame
Primary and secondary stability bty yhe resonance frequency analysis, evaluation of the suces and survival rates by the clinical analysis, and the evaluation of peri-implant bone level by the radiographic analysis

Countries

Brazil

Contacts

Public ContactElcio Marcantonio Junior

Faculdade de Odontologia de Araraquara-Unesp

elciojr@foar.unesp.br+55(16)33016378

Outcome results

None listed

Source: REBEC (via WHO ICTRP)